IPNEX

Licensable university IP

Inhibition of focal adhesion kinase for control of scar tissue formation

Inhibition of focal adhesion kinase for control of scar tissue formation is marketed for licensing by Stanford University (OTL). It is documented in US patent US 9,655,967. The current assignee of record is Leland Stanford Junior University. Google Patents reports its legal status as “Expired - Fee Related” (an automated indicator, not a legal determination). Its expected expiration is 2033-12-14.

Patent picture

FieldValueReliabilitySource
US patentUS 9,655,96795%HighGoogle Patents
Patent titleInhibition of focal adhesion kinase for control of scar tissue formation90%HighGoogle Patents
Current assigneeLeland Stanford Junior University80%GoodGoogle Patents
Original assigneeLeland Stanford Junior University85%GoodGoogle Patents
Legal statusExpired - Fee Related70%ModerateGoogle Patents
Filing date2012-12-0590%HighGoogle Patents
Priority date2011-12-0990%HighGoogle Patents
Publication date2017-05-2390%HighGoogle Patents
Expected expiration2033-12-1475%ModerateGoogle Patents
Reliability of each field, at a glance:
  • High 90% and up
  • Good 80 to 89%
  • Moderate 70 to 79%
Hover a bar for the exact figure; the Source column links the citation.

Legal status is Google Patents' automated indicator, not a legal determination.

Joined to US 9,655,967 by its printed patent number (a deterministic match), then enriched from public Google Patents data. Fields are shown only where resolved against a public source; unresolved fields are omitted, never guessed.

Original listing

This technology is marketed for licensing by Stanford University (OTL). View the original listing.